Full-Time

Industrial Property Global Manager F/M/X

Nemera

Nemera

1,001-5,000 employees

Designs, develops, manufactures drug delivery devices

No salary listed

Marcy-l'Étoile, France

In Person

Category
Legal & Compliance (2)
,
Requirements
  • Engineering degree, mechanical preferred
  • Fluent in English; French appreciated
  • CEIPI or equivalent experience; EQ appreciated
  • At least 15 years of experience and practice in an industry
  • Experience in infringement and licensing
  • Knowledge of the healthcare environment; experience in mergers and acquisitions are a plus
Responsibilities
  • Define and implement the company's intellectual property strategy in line with the group objectives, structure international governance, manage risks and opportunities, while optimizing the budget and ensuring ongoing competitive intelligence
  • Supervise and manage the IP portfolio, ensuring its monitoring, valuation, and protection
  • Support internal stakeholders (marketing, R&D, legal) in decision-making relating to IP issues
  • Act as an advisor and expert in interpreting IP rights, maintaining a balanced approach between business priorities and risk management
  • Monitor the performance of IP tools in use and suggest improvements where necessary
  • Manage the IP team, which consists of IP managers and assistants
  • Define (with HR) IP training needs of the organisation and coordinate / animate trainings
  • Instil an IP culture within teams through training, communication, and support initiatives, in order to strengthen understanding, ownership, and integration of IP issues in daily practices
  • Ensure the management and defence of intellectual property rights by coordinating legal actions, external counsel, and contractual compliance
  • Review and secure the IP clauses in contracts (development, services, supply, licences, transfers) prior to contract submission for approval, in coordination with the Legal Department and in accordance with the applicable rules
Desired Qualifications
  • French language ability (French appreciated)
  • EQ (equivalence) appreciated
  • Healthcare environment knowledge and experience in mergers and acquisitions are a plus

Nemera designs, develops, and manufactures drug delivery devices for pharmaceutical and biotech companies, spanning ophthalmic, nasal, buccal, parenteral, dermal, and inhalation routes. The devices are used to administer medicines and are developed and manufactured in collaboration with customers, often through co-development and customized production in a B2B model. It stands out by offering an end-to-end range of delivery solutions across multiple administration routes, supported by global manufacturing facilities and a wide distribution network. Its goal is to enable safer, more convenient self-administered therapies by providing scalable devices and related design and manufacturing services to partners.

Company Size

1,001-5,000

Company Stage

Acquired

Total Funding

$1.2B

Headquarters

La Verpillière, France

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • Rising demand for diabetes and obesity injection pens drives La Verpillière expansion, starting production 2027.
  • New Szczecin hall strengthens leadership in GLP-1 drug market for obesity therapies.
  • Milfra acquisition in June 2021 expands footprint in Brazil's gynecology and urology markets.

What critics are saying

  • SteadyMed's Releev One captures Symbioze market share in GLP-1 delivery within 12-18 months.
  • Ypsomed's dose accuracy wins Novo Nordisk contracts, undercutting La Verpillière capacity in 6-12 months.
  • SHL Medical's DAI platform displaces Nemera's devices in Eli Lilly obesity pens within 12-24 months.

What makes Nemera unique

  • Nemera specializes in drug delivery devices across ophthalmic, nasal, buccal, parenteral, dermal, and inhalation routes.
  • Launched Symbioze wearable injector in October 2021 for self-administration needs.
  • Introduced UniSpray unidose nasal system for emergency systemic drug delivery.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Nemera who can refer or advise you

Benefits

Remote Work Options

Company News

Nemera
Jul 21st, 2025
Nemera expands production capacity in Szczecin to strengthen leadership in GLP-1 drug market

Nemera, a global leader in the design, development, and manufacturing of drug delivery device solutions, has inaugurated a new production hall at its state-of-the-art facility in Szczecin, Poland.

Nemera
Oct 11th, 2023
Nemera extends manufacturing capabilities in North America

That's the new space Nemera has acquired to set up the next state-of-the-art manufacturing facility.

Jobmatch Ohio
Sep 15th, 2023
Printer Operator- Off Shift

In May of 2014, Rexam sold the plastics business and the Berlin Plant was acquired by Nemera, naming the prescription products business as Centor Inc.

The Real Deal
Jul 25th, 2023
Panattoni gets $26M for Vernon Hills industrial building

French medical device manufacturer Nemera is expanding its industrial footprint in suburban Chicago.

Nemera
Mar 10th, 2023
Nemera reinforces commitment to sustainability with first integrated ESG report

Nemera France SAS is thrilled to announce the publication of its first integrated ESG report.